secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocugen, Inc. (OCGN)
CIK:        0001372299
Form:       8-K
Filed at:   2025-02-12T23:59:59+00:00
Accession:  0001628280-25-005030
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocugen posts clinical presentation showing 84% reduction in mean total atrophy area in treated group
--------------------------------------------------------------------------------

- Presentation reports mean change in total atrophy area from baseline: 0.12±0.36 mm² (treated) vs 0.73±0.26 mm² (untreated), an 84% difference.
- A 44% efficacy metric also cited; specific endpoint not fully legible from exhibit.
- Presentation posted on website and may be used in investor discussions; no formal press release or guidance provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372299/000162828025005030/0001628280-25-005030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372299/000162828025005030/ocgn-20250212.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-005030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer